Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Oral Microbiol Immunol ; 21(4): 201-5, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16842502

ABSTRACT

Xylitol inhibits the glycolysis and growth of Streptococcus mutans, but to different degrees among strains. Thus, we studied the biochemical mechanism through which the inhibition varies, using S. mutans strains ATCC 31989, NCTN 10449, and NCIB 11723, which are highly sensitive, moderately sensitive, and resistant to xylitol, respectively, under strictly anaerobic conditions such as those found in deep layers of dental plaque. Xylitol (30 mM) decreased the rate of acid production from glucose (10 mM) in ATCC 31989, NCTC 10449, and NCIB 11723 by 86, 26, and 0%, respectively. The activities of the xylitol : phosphoenolpyruvate phosphotransferase system (PEP-PTS) relative to those of glucose : PEP-PTS were 120, 16, and 3%, respectively. In ATCC 31989 and NCTC 10449, intracellular accumulation of xylitol 5-phosphate and decreases of fructose 1,6-bisphosphate and glucose 6-phosphate were observed. Furthermore, in the presence of xylitol (30 mM), glucose : PEP-PTS activities decreased by 34, 17, and 0%, respectively. These findings indicated that the higher the xylitol : PEP-PTS activity was and the more effectively xylitol decreased glucose : PEP-PTS activity, the more sensitive the strain was to xylitol. These results suggest that the following inhibitory mechanisms are active in the xylitol-sensitive mutans streptococci: direct inhibition of glycolytic enzymes by xylitol 5-phosphate derived from xylitol : PEP-PTS and, possibly, indirect inhibition through competition for the phosphoryl donor, HPr-P, between glucose and xylitol : PEP-PTSs.


Subject(s)
Cariostatic Agents/pharmacology , Streptococcus mutans/drug effects , Sweetening Agents/pharmacology , Xylitol/pharmacology , Acetates/analysis , Anaerobiosis , Dental Plaque/microbiology , Formates/analysis , Fructose/metabolism , Fructosediphosphates/analysis , Glucose/metabolism , Glucose-6-Phosphate/analysis , Glycolysis/drug effects , Humans , Lactic Acid/analysis , Pentosephosphates/analysis , Phosphoenolpyruvate Sugar Phosphotransferase System/drug effects , Streptococcus mutans/classification , Streptococcus mutans/metabolism
2.
J Dairy Sci ; 89(8): 2973-6, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16840612

ABSTRACT

The antimicrobial susceptibility of 68 Staphylococcus aureus isolates collected during 2004 from milk of cows affected by subclinical mastitis was examined. The antimicrobial agents tested were the beta-lactams, penicillin G, amoxicillin, ampicillin, cloxacillin, amoxicillin + clavulanate, cephalonium, and cefoperazone; and other drugs including lincomycin, oxytetracycline, doxycycline, and kanamycin. Minimum inhibitory concentrations recorded show that only certain beta-lactamase-resistant penicillins (specifically cloxacillin) or penicillin combinations (amoxicillin + clavulanate) were consistently effective against Staph. aureus, whereas the other beta-lactam derivatives and drugs from other pharmacological groups were either moderately effective or ineffective. Thus, beta-lactamase-resistant penicillins are to be considered the antimicrobial agents of choice for treatment of bovine mastitis resulting from infection by Staph. aureus.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Bacterial Proteins/drug effects , Mastitis, Bovine/microbiology , Phosphoenolpyruvate Sugar Phosphotransferase System/drug effects , Animals , Cattle , Cephalosporins/administration & dosage , Clindamycin/administration & dosage , Female , Italy , Lincosamides , Macrolides/administration & dosage , Mastitis, Bovine/drug therapy , Microbial Sensitivity Tests , Penicillins/administration & dosage , Staphylococcal Infections/drug therapy , Staphylococcal Infections/veterinary
3.
Oral Microbiol Immunol ; 19(1): 31-8, 2004 Feb.
Article in English | MEDLINE | ID: mdl-14678472

ABSTRACT

Zinc is a known inhibitor of acid production by mutans streptococci. Our primary objective was to extend current knowledge of the physiologic bases for this inhibition and also for zinc inhibition of alkali production by Streptococcus rattus FA-1 and Streptococcus salivarius ATCC 13419. Zinc at concentrations as low as 0.01-0.1 mm not only inhibited acid production by cells of Streptococcus mutans GS-5 in suspensions or in biofilms but also sensitized glycolysis by intact cells to acidification. Zinc reversibly inhibited the F-ATPase of permeabilized cells of S. mutans with a 50% inhibitory concentration of about 1 mm for cells in suspensions. Zinc reversibly inhibited the phosphoenolpyruvate: sugar phosphotransferase system with 50% inhibition at about 0.3 mm ZnSO4, or about half that concentration when the zinc-citrate chelate was used. The reversibility of these inhibitory actions of zinc correlates with findings that it is mainly bacteriostatic rather than bactericidal. Zinc inhibited alkali production from arginine or urea and was a potent enzyme inhibitor for arginine deiminase of S. rattus FA-1 and for urease of S. salivarius. In addition, zinc citrate at high levels of 10-20 mm was weakly bactericidal.


Subject(s)
Anti-Infective Agents/pharmacology , Biofilms/drug effects , Streptococcus/drug effects , Zinc/pharmacology , Acids/antagonists & inhibitors , Adenosine Triphosphatases/antagonists & inhibitors , Alkalies/antagonists & inhibitors , Anti-Infective Agents/administration & dosage , Arginine/metabolism , Cell Membrane Permeability/drug effects , Chelating Agents/pharmacology , Citric Acid/pharmacology , Dose-Response Relationship, Drug , Enzyme Inhibitors/pharmacology , Glycolysis/drug effects , Humans , Hydrolases/antagonists & inhibitors , Mouth/microbiology , Phosphoenolpyruvate Sugar Phosphotransferase System/drug effects , Streptococcus/classification , Streptococcus/physiology , Streptococcus mutans/drug effects , Streptococcus mutans/physiology , Urease/antagonists & inhibitors , Zinc/administration & dosage
4.
Arch Microbiol ; 181(1): 26-34, 2004 Jan.
Article in English | MEDLINE | ID: mdl-14634719

ABSTRACT

An isogenic pair of Escherichia coli strains lacking ( pssA) and possessing (wild-type) the enzyme phosphatidylserine synthase was used to estimate the effects of the total lack of phosphatidylethanolamine (PE), the major phospholipid in E. coli membranes, on the activities of several sugar permeases (enzymes II) of the phosphoenolpyruvate:sugar phosphotransferase system (PTS). The mutant exhibits greatly elevated levels of phosphatidylglycerol (PG), a lipid that has been reported to stimulate the in vitro activities of several PTS permeases. The activities, thermal stabilities, and detergent sensitivities of three PTS permeases, the glucose enzyme II (II(Glc)), the mannose enzyme II (II(Man)) and the mannitol enzyme II (II(Mtl)), were characterized. Western blot analyses revealed that the protein levels of II(Glc) were not appreciably altered by the loss of PE. In the pssA mutant, II(Glc) and II(Man) activities were depressed both in vivo and in vitro, with the in vivo transport activities being depressed much more than the in vitro phosphorylation activities. II(Mtl) also exhibited depressed transport activity in vivo but showed normal phosphorylation activities in vitro. II(Man) and II(Glc) exhibited greater thermal lability in the pssA mutant membranes than in the wild-type membranes, but II(Mtl) showed enhanced thermal stability. All three enzymes were activated by exposure to TritonX100 (0.4%) or deoxycholate (0.2%) and inhibited by SDS (0.1%), but II(Mtl) was the least affected. II(Man) and, to a lesser degree, II(Glc) were more sensitive to detergent treatments in the pssA mutant membranes than in the wild-type membranes while II(Mtl) showed no differential effect. The results suggest that all three PTS permeases exhibit strong phospholipid dependencies for transport activity in vivo but much weaker and differential dependencies for phosphorylation activities in vitro, with II(Man) exhibiting the greatest and II(Mtl) the least dependency. The effects of lipid composition on thermal sensitivities and detergent activation responses paralleled the effects on in vitro phosphorylation activities. These results together with those previously published suggest that, while the in vivo transport activities of all PTS enzymes II require an appropriate anionic to zwitterionic phospholipid balance, the in vitro phosphorylation activities of these same enzymes show much weaker and differential dependencies. Alteration of the phospholipid composition of the membrane thus allows functional dissection of transport from the phosphorylation activities of PTS enzyme complexes.


Subject(s)
CDPdiacylglycerol-Serine O-Phosphatidyltransferase/genetics , CDPdiacylglycerol-Serine O-Phosphatidyltransferase/metabolism , Carbohydrate Metabolism , Escherichia coli/genetics , Escherichia coli/metabolism , Phosphatidylethanolamines/physiology , Phosphoenolpyruvate Sugar Phosphotransferase System/physiology , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Biological Transport/physiology , Cell Membrane/chemistry , Detergents/pharmacology , Enzyme Stability , Escherichia coli Proteins , Hot Temperature , Monosaccharide Transport Proteins , Phosphatidylglycerols/analysis , Phosphoenolpyruvate Sugar Phosphotransferase System/drug effects , Phosphoenolpyruvate Sugar Phosphotransferase System/metabolism , Phosphorylation
5.
Cell ; 114(6): 673-88, 2003 Sep 19.
Article in English | MEDLINE | ID: mdl-14505568

ABSTRACT

It is poorly understood how apoptotic signals arising from DNA damage are transmitted to mitochondria, which release apoptogenic factors into the cytoplasm that activate downstream destruction programs. Here, we identify histone H1.2 as a cytochrome c-releasing factor that appears in the cytoplasm after exposure to X-ray irradiation. While all nuclear histone H1 forms are released into the cytoplasm in a p53-dependent manner after irradiation, only H1.2, but not other H1 forms, induced cytochrome c release from isolated mitochondria in a Bak-dependent manner. Reducing H1.2 expression enhanced cellular resistance to apoptosis induced by X-ray irradiation or etoposide, but not that induced by other stimuli including TNF-alpha and UV irradiation. H1.2-deficient mice exhibited increased cellular resistance in thymocytes and the small intestine to X-ray-induced apoptosis. These results indicate that histone H1.2 plays an important role in transmitting apoptotic signals from the nucleus to the mitochondria following DNA double-strand breaks.


Subject(s)
Apoptosis/genetics , Cell Nucleus/metabolism , DNA Damage/genetics , Eukaryotic Cells/metabolism , Histones/genetics , Animals , Apoptosis/radiation effects , Apoptotic Protease-Activating Factor 1 , Cell Nucleus/genetics , Cell Nucleus/radiation effects , Cytochrome c Group/genetics , DNA Damage/radiation effects , Escherichia coli Proteins , Etoposide/pharmacology , Eukaryotic Cells/radiation effects , Histones/radiation effects , Humans , Intestine, Small/radiation effects , Male , Membrane Proteins/drug effects , Membrane Proteins/genetics , Membrane Proteins/metabolism , Mice , Mice, Knockout , Mitochondria/genetics , Mitochondria/radiation effects , Phosphoenolpyruvate Sugar Phosphotransferase System/drug effects , Phosphoenolpyruvate Sugar Phosphotransferase System/genetics , Protein Isoforms/genetics , Protein Isoforms/radiation effects , Proteins/genetics , Proteins/metabolism , Rats , Thymus Gland/radiation effects , Tumor Necrosis Factor-alpha/pharmacology , Tumor Suppressor Protein p53/genetics , Tumor Suppressor Protein p53/metabolism , Ultraviolet Rays/adverse effects , X-Rays/adverse effects , bcl-2 Homologous Antagonist-Killer Protein
6.
Biochimie ; 85(7): 633-8, 2003 Jul.
Article in English | MEDLINE | ID: mdl-14505817

ABSTRACT

The sigma(54) subunit of the RNA polymerase directs the expression of specific operons in association with cognate activators. Three different activators have been detected in the Listeria monocytogenes genome on the basis of the high conservation of a specific domain. Among them, the LacR activator, of the LevR family, was found just upstream from a newly described sigma(54)-dependent operon, lpo, which presents a classical -24/-12 consensus promoter. The lpo operon encodes proteins similar to subunits of a PTS permease (EII) of the lactose family, namely LpoA (IIA) and LpoB (IIB). It also encodes a third putative protein, LpoO, with an unknown function but sharing high similarity with proteins also encoded within PTS operons from other bacteria and bearing a RGD motif. The expression of lpo was clearly dependent on LacR and sigma(54), and was induced by cellobiose, chitobiose and lactose. It underlies that the lpo operon likely encodes proteins involved in the utilization of these sugars by L. monocytogenes.


Subject(s)
Carbohydrate Metabolism , DNA-Binding Proteins , DNA-Directed RNA Polymerases/physiology , Listeria monocytogenes/genetics , Operon/genetics , Phosphoenolpyruvate Sugar Phosphotransferase System/genetics , Sigma Factor/physiology , Animals , Bacterial Proteins/genetics , Bacterial Proteins/physiology , Base Sequence , Cellobiose/pharmacology , Disaccharides/pharmacology , Enhancer Elements, Genetic/genetics , Enhancer Elements, Genetic/physiology , Lac Repressors , Lactose/pharmacology , Listeria monocytogenes/enzymology , Molecular Sequence Data , Operon/drug effects , Phosphoenolpyruvate Sugar Phosphotransferase System/chemistry , Phosphoenolpyruvate Sugar Phosphotransferase System/drug effects , RNA Polymerase Sigma 54 , Repressor Proteins/genetics , Repressor Proteins/physiology
7.
J Bacteriol ; 185(7): 2243-50, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12644495

ABSTRACT

The sgaTBA genes of Escherichia coli encode a putative 12-transmembrane alpha-helical segment (12 TMS) transporter, an enzyme IIB-like protein and an enzyme IIA-like protein of the phosphotransferase system (PTS), respectively. We show that all three proteins as well as the energy-coupling PTS proteins, enzyme I and HPr, are required for the anaerobic utilization and uptake of L-ascorbate in vivo and its phosphoenolpyruvate-dependent phosphorylation in vitro. The transporter exhibits an apparent K(m) for L-ascorbate of 9 micro M and is highly specific. The sgaTBA genes are regulated at the transcriptional level by the yjfQ gene product, as well as by Crp and Fnr. The yjfR gene product is essential for L-ascorbate utilization and probably encodes a cytoplasmic L-ascorbate 6-phosphate lactonase. We conclude that SgaT represents a novel prototypical enzyme IIC that functions with SgaA and SgaB to allow phosphoryl transfer from HPr(his-P) to L-ascorbate via the phosphoryl transfer pathway: [pathway: see text].


Subject(s)
Ascorbic Acid/metabolism , Carrier Proteins/genetics , Carrier Proteins/metabolism , Escherichia coli Proteins/chemistry , Escherichia coli Proteins/genetics , Escherichia coli Proteins/metabolism , Membrane Transport Proteins/chemistry , Membrane Transport Proteins/genetics , Phosphoenolpyruvate Sugar Phosphotransferase System/genetics , Phosphoenolpyruvate Sugar Phosphotransferase System/metabolism , Anaerobiosis , Ascorbic Acid/analogs & derivatives , Ascorbic Acid/pharmacology , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Biological Transport, Active , Carrier Proteins/drug effects , Cell Division/genetics , Cyclic AMP Receptor Protein/genetics , Cyclic AMP Receptor Protein/metabolism , Escherichia coli/drug effects , Escherichia coli/genetics , Escherichia coli/metabolism , Escherichia coli Proteins/drug effects , Gene Expression Regulation, Bacterial , Iron-Sulfur Proteins/genetics , Iron-Sulfur Proteins/metabolism , Membrane Transport Proteins/drug effects , Mutation , Phosphoenolpyruvate Sugar Phosphotransferase System/drug effects , Phosphorylation , Repressor Proteins/genetics , Repressor Proteins/metabolism , Transcription, Genetic
8.
Eur J Biochem ; 269(20): 4969-80, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12383255

ABSTRACT

Thirteen glucose analogues bearing electrophilic groups were synthesized (five of them for the first time) and screened as inhibitors of the glucose transporter (EIIGlc) of the Escherichia coli phosphoenolpyruvate-sugar phosphotransferase system (PTS). 2',3'-Epoxypropyl beta-d-glucopyranoside (3a) is an inhibitor and also a pseudosubstrate. Five analogues are inhibitors of nonvectorial Glc phosphorylation by EIIGlc but not pseudosubstrates. They are selective for EIIGlc as demonstrated by comparison with EIIMan, another Glc-specific but structurally different transporter. 3a is the only analogue that inhibits EIIGlc by binding to the high-affinity cytoplasmic binding site and also strongly inhibits sugar uptake mediated by this transporter. The most potent inhibitor in vitro, methyl 6,7-anhydro-d,l-glycero-alpha-d-gluco-heptopyranoside (1d), preferentially interacts with the low-affinity cytoplasmic site but only weakly inhibits Glc uptake. Binding and/or phosphorylation from the cytoplasmic side of EIIGlc is more permissive than sugar binding and/or translocation of substrates via the periplasmic site. EIIGlc is rapidly inactivated by the 6-O-bromoacetyl esters of methyl alpha-d-glucopyranoside (1a) and methyl alpha-d-mannopyranoside (1c), methyl 6-deoxy-6-isothiocyanato-alpha-d-glucopyranoside (1e), beta-d-glucopyranosyl isothiocyanate (3c) and beta-d-glucopyranosyl phenyl isothiocyanate (3d). Phosphorylation of EIIGlc protects, indicating that inactivation occurs by alkylation of Cys421. Glc does not protect, but sensitizes EIIGlc for inactivation by 1e and 3d, which is interpreted as the effect of glucose-induced conformational changes in the dimeric transporter. Glc also sensitizes EIIGlc for inactivation by 1a and 1c of uptake by starved cells. This indicates that Cys421 which is located on the cytoplasmic domain of EIIGlc becomes transiently accessible to substrate analogues on the periplasmic side of the transporter.


Subject(s)
Enzyme Inhibitors/chemistry , Enzyme Inhibitors/pharmacology , Epoxy Compounds/chemistry , Epoxy Compounds/pharmacology , Escherichia coli Proteins/antagonists & inhibitors , Glucosides/chemistry , Glucosides/pharmacology , Phosphoenolpyruvate Sugar Phosphotransferase System/antagonists & inhibitors , Binding Sites , Biochemistry/methods , Biological Transport , Cysteine/chemistry , Cysteine/metabolism , Drug Design , Drug Evaluation, Preclinical , Enzyme Activation/drug effects , Enzyme Inhibitors/chemical synthesis , Epoxy Compounds/chemical synthesis , Escherichia coli/drug effects , Escherichia coli/metabolism , Escherichia coli Proteins/metabolism , Glucose/chemistry , Glucose/metabolism , Glucosides/chemical synthesis , Glucosides/metabolism , Microbial Sensitivity Tests , Phosphoenolpyruvate Sugar Phosphotransferase System/drug effects , Phosphoenolpyruvate Sugar Phosphotransferase System/metabolism , Phosphorylation , Structure-Activity Relationship
9.
J Dent Res ; 71(5): 1159-65, 1992 May.
Article in English | MEDLINE | ID: mdl-1607433

ABSTRACT

The intracellular pH (pHi) optimum for glycolysis in Streptococcus mutans Ingbritt was determined to be 7.0 by use of the ionophore gramicidin for manipulation of pHi. Glycolytic activity decreased to zero as the pHi was lowered from 7.0 to 5.0. In contrast, glycolysis had an extracellular pH (pHo) optimum of 6.0 with a much broader profile. The relative insensitivity of glycolysis to the lowering of pHo was attributed to the ability of S. mutans to maintain a transmembrane pH gradient (delta pH, inside more alkaline) at low pHo. At a pHo of 5.0, glycolyzing cells of S. mutans maintained a delta pH of 1.37 +/- 0.09 units. The maintenance of this delta pH was dependent on the concentration of potassium ions in the extracellular medium. Potassium was rapidly taken up by glycolyzing cells of S. mutans at a rate of 70 nmol/mg dry weight/min. This uptake was dependent on the presence of both ATP and a proton motive-force (delta p). The addition of N-N'-dicyclohexylcarbodiimide (DCCD) to glycolyzing cells of S. mutans caused a partial collapse of the delta pH. Growth of S. mutants at pHo 5.5 in continuous culture resulted in the maintenance of a delta pH larger than that produced by cells grown at pH 7.0. These results suggest the presence of a proton-translocating F1Fo-ATPase in S. mutans whose activity is regulated by the intracellular pH and transmembrane electrical potential (delta psi). The production of an artificial delta p of 124 mV across the cell membrane of S. mutans did not result in proton movement through the F1Fo-ATPase coupled to ATP synthesis.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Streptococcus mutans/metabolism , Acids/metabolism , Adenosine Triphosphate/analysis , Cell Membrane/metabolism , Cytoplasm/chemistry , Cytoplasm/metabolism , Fluorides/pharmacology , Glucose/metabolism , Glycolysis , Hydrogen-Ion Concentration , Phosphoenolpyruvate Sugar Phosphotransferase System/analysis , Phosphoenolpyruvate Sugar Phosphotransferase System/drug effects , Phosphoenolpyruvate Sugar Phosphotransferase System/metabolism , Phosphorylation/drug effects , Potassium/analysis , Potassium/metabolism , Potassium/pharmacology , Sodium/pharmacology , Streptococcus mutans/chemistry , Streptococcus mutans/drug effects , Streptococcus sanguis/chemistry , Streptococcus sanguis/drug effects , Streptococcus sanguis/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...